These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8174823)

  • 1. Combined testing for viral markers.
    Barbara J
    Dev Biol Stand; 1993; 81():87-9. PubMed ID: 8174823
    [No Abstract]   [Full Text] [Related]  

  • 2. Decisions on screening for viral markers in blood donors.
    Zuck TF
    Dev Biol Stand; 1993; 81():91-100. PubMed ID: 8174824
    [No Abstract]   [Full Text] [Related]  

  • 3. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral safety considerations in immunoglobulin preparations].
    Gómez Manzano P; Escrivá CA; Salmerón García F; Alonso Verduras C
    Sangre (Barc); 1997 Jun; 42(3):199-203. PubMed ID: 9381262
    [No Abstract]   [Full Text] [Related]  

  • 5. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topicality of serologic screening of human immunodeficiency virus infections in adults].
    Dubrous P; Koeck JL; Coulot P; Blanchard de Vaucouleurs A
    Pathol Biol (Paris); 1998 Jan; 46(1):61-6. PubMed ID: 9769938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing vertical virus infections: the role of serologic screening of pregnant women.
    Berger A; Doerr HW
    Med Microbiol Immunol; 2018 Nov; 207(5-6):249-253. PubMed ID: 29971491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
    Coste J; Reesink HW; Engelfriet CP; Laperche S; Brown S; Busch MP; Cuijpers HT; Elgin R; Ekermo B; Epstein JS; Flesland O; Heier HE; Henn G; Hernandez JM; Hewlett IK; Hyland C; Keller AJ; Krusius T; Levicnik-Stezina S; Levy G; Lin CK; Margaritis AR; Muylle L; Niederhauser C; Pastila S; Pillonel J; Pineau J; van der Poel CL; Politis C; Roth WK; Sauleda S; Seed CR; Sondag-Thull D; Stramer SL; Strong M; Vamvakas EC; Velati C; Vesga MA; Zanetti A
    Vox Sang; 2005 May; 88(4):289-303. PubMed ID: 15877653
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV, HBV and HCV: new developments related to transfusion safety.
    Busch MP
    Vox Sang; 2000; 78 Suppl 2():253-6. PubMed ID: 10938963
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses?
    Vox Sang; 1997; 73(2):97-104. PubMed ID: 9304779
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleic acid testing for virus screening in Polish blood donors.
    Brojer E; Łetowska M; Gronowska A
    Transfus Med; 2004 Feb; 14(1):79-80. PubMed ID: 15043598
    [No Abstract]   [Full Text] [Related]  

  • 12. Will blood transfusion ever be safe enough?
    Klein HG
    JAMA; 2000 Jul; 284(2):238-40. PubMed ID: 10889600
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan.
    Yugi H; Hino S; Satake M; Tadodoro K
    Vox Sang; 2005 Nov; 89(4):265. PubMed ID: 16262762
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine HIV screening, Part 2: beyond testing and referral.
    Gallant JE
    AIDS Read; 2009; 19(6):211-2. PubMed ID: 19642238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serologic screening for coeliac disease].
    Rumessen JJ
    Ugeskr Laeger; 2004 May; 166(22):2142-4. PubMed ID: 15222165
    [No Abstract]   [Full Text] [Related]  

  • 16. [The improvement of a serological screening method in blood transfusion].
    Cernescu C; Cristea A; Deutsch I
    Rev Roum Virol; 1990; 41(3-4):181-95. PubMed ID: 2099829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid tests for blood donor screening in Africa.
    La Raja M
    Transfusion; 2009 Dec; 49(12):2773-4. PubMed ID: 20163692
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
    Malm K; von Sydow M; Andersson S
    Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.